ias - Monitoring
  • KI-Tools
  • Suche
  • Publizieren
  • Mediathek
Seite wählen
Bayer and RIKEN partner for novel drug discovery – The Pharma Letter

Bayer and RIKEN partner for novel drug discovery – The Pharma Letter

von Tobias Borgers | Okt. 9, 2019 | Bayer

Bayer and RIKEN partner for novel drug discovery  The Pharma Letter Link zum Originalbeitrag
Pharmaceutical Tablet Packaging Equipments Market Growing Demand, Competition, Investment Opportunities and Forecast 2025 – League Finals

Pharmaceutical Tablet Packaging Equipments Market Growing Demand, Competition, Investment Opportunities and Forecast 2025 – League Finals

von Tobias Borgers | Okt. 9, 2019 | Romaco

Sanchita KasliwalSanchita Kasliwal has a vast experience in the field of Machinery and Equipment. She has been a part of the industry for many years, which has granted her access to insightful details. Check out her opinion about the latest in the industry. Latest...
Hormon replacement therapy Market 2019-2028| Bayer Pharma AG, Abbott Laboratories, AbbVie

Hormon replacement therapy Market 2019-2028| Bayer Pharma AG, Abbott Laboratories, AbbVie

von Tobias Borgers | Okt. 9, 2019 | Abbvie

New York City, NY: Oct 09, 2019 – Published via (Wired Release) – The global Hormon replacement therapy market is comprehensively researched and analyzed in the report by MarketResearch.Biz to help out market players to improve their business plans and ensure...
Blood Preparation Market Trends And Forecast 2019-2028| Bristol-Myers Squibb Company, Pfizer, Baxter Healthcare Corporation

Blood Preparation Market Trends And Forecast 2019-2028| Bristol-Myers Squibb Company, Pfizer, Baxter Healthcare Corporation

von Tobias Borgers | Okt. 9, 2019 | Allgemein

New York City, NY: Oct 09, 2019 – Published via (Wired Release) – The global Blood Preparation market is comprehensively researched and analyzed in the report by MarketResearch.Biz to help out market players to improve their business plans and ensure long-term...
Roche presents new OCREVUS (ocrelizumab) biomarker data that increase understanding of disease progression in multiple sclerosis at ECTRIMS

Roche presents new OCREVUS (ocrelizumab) biomarker data that increase understanding of disease progression in multiple sclerosis at ECTRIMS

von Tobias Borgers | Okt. 9, 2019 | Roche

Media Release Basel, 10 September 2019 Roche presents new OCREVUS (ocrelizumab) biomarker data that increase understanding of disease progression in multiple sclerosis at ECTRIMS Blood neurofilament light chain (NfL) levels were significantly lowered following OCREVUS...
« Ältere Einträge
Nächste Einträge »

Kategorien

Schlagwörter

Breaking News Kunden Location Production Products prozesstechnik online Wettbewerb
  • Backend
  • Alle Beiträge
  • Dokumentation
  • Logout